A new study has found that the diabetes drug tirzepatide helps people lower their blood sugar and lose weight more quickly ...

The GIP receptor agonist part works very similarly, mimicking the GIP hormone, which is also released after eating to trigger insulin production. It’s also linked with feelings of fullness.

In a world inundated with weight loss products and miracle supplements, it can be overwhelming to determine what truly works. Enter LipoVive, a groundbreaking supplement that has captured the ...

AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra’s obesity drug. AI takes center stage at HIMSS ...

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...

It mimics two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). When you eat, ...

It has been established that when food is consumed, the body releases hormones called incretins to help regulate blood sugar, appetite and energy use. Two important incretins, GLP-1 and GIP ...

while Eli Lilly's own drug Zepbound targets both GLP-1 and another hormone called GIP. Some drugmakers believe that targeting amylin could reduce the gastrointestinal side effects typically seen ...